About Helix
Helix is the leading enterprise genomics platform that transforms health systems and enables life science organizations to leverage the power of genomics across their enterprise, creating strategic value and fueling future growth. The company brings together every component of genomic medicine into a single, unified platform, serving providers, patients, health systems, health plans, and life sciences organizations. Helix operates the Helix Research Network®, North America's largest precision health network, which accelerates genomic discoveries and translates them into real-world clinical impact. The platform offers comprehensive solutions including population genomics, clinical testing through Helix Diagnostics, and research and discovery capabilities via Helix GenoSphere™, which provides access to the largest clinico-genomic database with 13+ years of longitudinal medical records. The company's mission is to empower every person to improve their life through DNA by weaving genomics into the fabric of healthcare. Helix has sequenced over 500,000 exomes and serves more than 1.5 million lives in enterprise genomics programs. The platform simplifies the complexity of genomic medicine through easy test ordering, clinical decision support, and EHR integration, enabling healthcare providers to focus on patient care while leveraging the power of precision medicine at population scale.
Mission & Story
Mission
Empowering every person to improve their life through DNA.
Clinical Focus
Medical conditions and clinical areas addressed by Helix.
Who It Serves
Milestones & Awards
Recent Milestones
Multi-year agreement with Alnylam announced March 2026 for precision medicine development; Partnership with Mawi DNA Technologies announced February 2026 to expand non-invasive genomic sample collection; Received 2026 BIG Innovation Award in January 2026
Awards & Recognition
2026 BIG Innovation Award for advancing genomics and precision medicine
Key Partnerships
Social & Media
Latest Updates
Why the Best Patient Recruitment Starts with the Genome
1w ago
Finding the Right Population Faster: Inside Helix's GenoSphere™ and Cohort Builder
1mo ago
When Genetics Are Ignored at the Pharmacy
2mo ago
Better Data, Better Diagnoses: The Power of Shared Genomic Data
3mo ago
How Record Q4 2025 Growth in GenoSphere Clinico-genomic Cohorts Is Advancing Precision Medicine Research
3mo ago
Company Details
- Founded
- 2016
- Headquarters
- San Mateo, CA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.